99 related articles for article (PubMed ID: 3600228)
1. [Radioimmunological methods in the diagnosis of metastases of thyroid cancer].
Lozinskaia IN; Vikman IaE
Med Radiol (Mosk); 1987 Jun; 32(6):6-9. PubMed ID: 3600228
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunoassay in the diagnosis of thyroid cancer].
Kashkadamov AV; Komissarenko IV
Med Radiol (Mosk); 1983 Aug; 28(8):44-7. PubMed ID: 6412029
[TBL] [Abstract][Full Text] [Related]
3. Humoral markers for thyroid carcinoma.
Pacini F; Martino E; Bambini G; Aghini-Lombardi F; Taddei D; Lari R; Pinchera A; Baschieri L
Cancer Detect Prev; 1985; 8(1-2):17-22. PubMed ID: 4064037
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of serum thyroglobulin from patients with bone metastases from follicular carcinoma of the thyroid.
Kumar A; Shah DH; Thakare UR
Indian J Biochem Biophys; 1991 Jun; 28(3):198-202. PubMed ID: 1786970
[TBL] [Abstract][Full Text] [Related]
5. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
Vogel J; Oehr P; Grouls V
Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
[No Abstract] [Full Text] [Related]
7. [Use of tumor markers in monitoring thyroid carcinoma].
Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis of thyroid tumors.
DeGroot LJ
Ann Clin Lab Sci; 1983; 13(2):77-82. PubMed ID: 6305255
[No Abstract] [Full Text] [Related]
9. [Blood plasma content of hormones and carcinoembryonic antigen in tumorous and nontumorous disease of the thyroid].
Ivanov PK; Tkacheva GA
Vopr Onkol; 1982; 28(4):29-34. PubMed ID: 7090265
[TBL] [Abstract][Full Text] [Related]
10. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
[TBL] [Abstract][Full Text] [Related]
11. [Determination of calcitonin and parathyrin in blood serum in the diagnosis of tumor metastases to bone].
Smirnov IuN
Med Radiol (Mosk); 1986 Apr; 31(4):9-12. PubMed ID: 3959820
[TBL] [Abstract][Full Text] [Related]
12. [Humoral markers in thyroid carcinoma].
Pinchera A; Pacini F; Martino E; Anelli S
Minerva Med; 1986 Nov; 77(44):2089-91. PubMed ID: 3785723
[No Abstract] [Full Text] [Related]
13. [Assay of thyroglobulin in the study of patients with differentiated thyroid carcinoma].
Limbert E; Dinarés JM; Santos MA; Henriques MM
Acta Med Port; 1984 Mar; 5(3):73-8. PubMed ID: 6731030
[No Abstract] [Full Text] [Related]
14. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
Carmignani F; Piscopello L; Sammartini C
Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442
[TBL] [Abstract][Full Text] [Related]
15. [Serum carcinoembryonic antigen levels in breast cancer].
Haim N; Bartal AH; Cohen Y; Cordova T; Ayalon D
Harefuah; 1980 Feb; 98(4):152-4. PubMed ID: 7399356
[No Abstract] [Full Text] [Related]
16. [Tumor markers for endocrine neoplasms].
Okamoto T
Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers for thyroid malignant disease].
Tamura K
Nihon Rinsho; 2011 Mar; 69 Suppl 2():298-303. PubMed ID: 21830558
[No Abstract] [Full Text] [Related]
18. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
Polevaia EB; Ivanov VM; Koposova TL; Gabuniia RI; Chinareva IV
Vopr Onkol; 1984; 30(4):23-9. PubMed ID: 6730403
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
Surg Forum; 1979; 30():120-1. PubMed ID: 395674
[No Abstract] [Full Text] [Related]
20. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
